Best Artax Podcasts (2025)

1
A Very Merry Cringemas 1:12:38

Play Pause

2d ago1:12:38

1:12:38

Merry Cringemas everybody! And to live up to that name, we've got a show teeming with awkward first kisses, OfficeMax Santa gifts, and a poem Terri wrote to her boyfriend in 1993. Plus: 90s gifts that wouldn't exist today (hi, answering machines!) and our (least) favorite Christmas movie. We wish you a safe and happy holiday season, and thank you f…

1
When Your Immune System Overreacts...Prof. Dr. Niels Riedemann, Co-Founder & CEO, InflaRx 21:52

3d ago21:52

21:52

This week on BioTech Nation, we explore what happens when your immune system overreacts. Professor Niels Riedemann, CEO of InflaRx, explains how the body’s defense system can sometimes cause more harm than good, leading to serious conditions like rheumatoid arthritis, severe COVID-19, and lung failure. Learn how InflaRx is developing treatments to …

1
Renewed Potential: Reviving an ALS Drug...Dr. Ari Azhir, Founder & CEO, Neuvivo 17:47

9d ago17:47

17:47

This week on Biotech Nation, Dr. Ari Azhir, Founder and CEO of Neuvivo, shares the incredible journey of an ALS drug that was once abandoned, but is now making its way toward FDA approval. After two failed phase two trials, the drug was left behind until Dr. Azhir and her team discovered a crucial mistake in the trial data. Now with new insights an…

1
Kim Bows to Peer Pressure in 1988 1:06:09

9d ago1:06:09

1:06:09

In March of 1988, when Kim was in the sixth grade, she watched as the boys goaded her friend Amy to walk out over the surface of an icy pond — at which point the ice started to crack, and then broke beneath her. And everyone…laughed. Hysterically. It was a very shallow pond, and no one was hurt. But the peer pressure of it all haunts Kim to this da…

1
Preventing Pressure Injuries: Detecting the Invisible Signs, Martin Burns, CEO Bruin Biometrics 20:22

16d ago20:22

20:22

This week on BioTech Nation, Bruin Biometrics CEO Martin Burns talks about a new diagnostic tool being used to detect and prevent potentially fatal bedsores in their earliest stages.By Moira Gunn

1
You've Got Lice 59:00

16d ago59:00

59:00

In this episode of Generation Artax, we take a trip back to the early 90s when Terri left for college and Kim was inconsolable. And Lori went off to college and became a huge star. Also: REM sleep, room temps, and a bad case of lice. Buckle up and enjoy. Visit our website: www.generationartax.com and join our mailing list for the latest information…

1
Are we moving from Dr. Google to Dr. ChatGPT??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 7:28

21d ago7:28

7:28

For years, we've all turned to Google to self-diagnose every cough, rash, and weird pain. Dr. Daniel Kraft says the shift is happening, from Dr. Google to Dr. ChatGPT.By Moira Gunn

1
Dear Future Lori: Don't Be a Slut 1:04:39

24d ago1:04:39

1:04:39

In this episode of Generation Artax, 13 yo Lori hopes her future self isn't a huge slut, and then doubles down on catholicism. Kim fails to make the basketball team. We all take Tae Kwon Do. Plus: movies that make us cry and one 80s movie we should not have been watching. Strap in and let's begin. Visit our website: www.generationartax.com and join…

1
Connecting the Data that Changes Medicine, Dr. Lincoln Nadauld, President & CEO, Culmination Bio 18:27

28d ago18:27

18:27

This week on Biotech Nation, Dr. Lincoln Nadauld shares how Culmination Bio is using 9 million preserved tissue samples and decades of patient data to improve how we understand and treat diseases. From discovering patterns in cancer treatments to exploring breakthroughs in heart and autoimmune diseases, this unique approach is changing medicine.…

1
The Virginity Pact of 1987 and Other Promises We Made 35:21

1M ago35:21

35:21

We kick off this episode of Generation Artax in 1987, where we find Terri in the eighth grade, struggling with the moral complexities of virginity pacts, and if saying you may have sex someday before marriage is as bad as actually doing it. Also, whether Jon Bon Jovi is to blame for at least part of it. Plus, hear what very different shenanigans Ki…

1
Which of Us Are Witches? 31:32

1M ago31:32

31:32

In this episode, why it's worth revisiting your diaries, how religion warped our brains, and why Lori grew up under the impression that Jesus was a big bummer. Plus: Let's get into the quantum physics of it all: Kim manifests the fuck out of a pair of glasses, Terri can channel dead pets, and why Lori thinks believing is seeing. Visit our website: …

1
Meet Your Sisters: Who We Are, Who Dumped Us and Why 43:06

1M ago43:06

43:06

We will not kick off our FIRST episode of Generation Artax by introducing ourselves, because that puts Lori and Kim in a cold sweat. Instead, we take turns introducing the other sisters to you, to give you a lay of the land of what you're wandering into. Plus: How Terri wanted to get out of every relationship with boys (#gay); Lori was always told …

1
Correcting Gene-based Frontotemporal Dementia, Lisa Deschamps, CEO Aviado Bio 14:41

1M ago14:41

14:41

What if we could fix the gene that causes dementia? In this episode, Aviado Bio CEO Lisa Deschamps tells us how her team is working to correct the gene driving many cases of frontotemporal dementia.By Moira Gunn

1
Tuning your own DNA?? Dr. Derek Jantz, Chief Scientific Officer, Tune Therapeutics 17:38

1M ago17:38

17:38

What if you could tune your DNA to fix any mistakes? Dr. Derek Jantz from Tune Therapeutics talks about tuning DNA, not just with humans, but stopping the Hepatitis B virus in its tracks.By Moira Gunn

1
Trailer 2:37

1M ago2:37

2:37

By Terri Trespicio, Kim O'Brien, Lori Regan

1
A New Way to Treat Wounds?? Dr. Ned Swanson, Co-Founder, President & Chief Medical Officer, Polarity Bio 15:02

2M ago15:02

15:02

Imagine a world where the toughest wounds heal twice as fast, and patients get their lives back sooner than anyone thought possible. Dr. Ned Swanson, the President and Chief Medical Officer of Polarity Bio, tells us about their approach to healing serious, hard-to-treat skin wounds. In early trials, it's twice as effective as the current treatment …

1
Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma 17:12

2M ago17:12

17:12

40% of all rheumatoid arthritis patients do not respond to any of the current drugs. Rob Armstrong, CEO of Artax Biopharma, aims to bring new hope for those patients who've been left without effective treatment options.By Moira Gunn

1
Treating babies with congenital heart defects... Dr. Joshua Hare, Co-Founder and Chief Scientific Officer, Longeveron 23:57

2M ago23:57

23:57

Can you imagine parents expecting a baby, going in for an ultrasound, and finding out that their baby is missing the heart's left ventricle? This week on BioTech Nation, Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, talks about how they are testing the use of stem cells to treat babies born with a serious congenital heart …

1
A New Approach to Flu Shots! Dr. Jeff Stein, President & CEO, Cidara Therapeutics 19:23

2M ago19:23

19:23

This week on BioTech Nation, Dr. Jeff Stein, President & CEO of Cidara Therapeutics, brings up promising news about a new approach to flu shots.By Moira Gunn

1
New treatment being tested for pre-term babies... Dr. Marc Salzberg, CEO and Chief Medical Officer, Airway Therapeutics 22:20

3M ago22:20

22:20

Dr. Marc Salzberg, CEO & Chief Medical Officer of Airway Therapeutics, talks about what they are doing to help preterm babies. It may all boil down to delivering these babies a single protein as soon as they are born.By Moira Gunn

1
A Smarter Path to Curing Diseases… Dr. Avak Kahvejian Founding CEO, Cellarity 19:44

3M ago19:44

19:44

Dr. Avak Kahvejian, Founding CEO of Cellarity, explains their new approach to discovering drugs by using AI to look at how cells behave as a whole, rather than focusing on one part of the problem. This approach could lead to faster development of better treatments, such as a pill for sickle cell disease.…

1
No More Vaccines? Research Funding? Paul Hastings, CEO, Nkarta and former Chair, BIO 24:38

3M ago24:38

24:38

This week on Biotech Nation, Paul Hastings, CEO of Nkarta and former chair of BIO—the Biotechnology Innovation Organization—discusses the impact of cuts to research funding and stepping away from recommending vaccines—what this means for you and the biotech industry.By Moira Gunn

1
How Hydrated are YOU? A Simple Wearable can do it! Dr. Mark Kendall, CEO, WearOptimo 20:08

4M ago20:08

20:08

This week on BioTech Nation, Dr. Mark Kendall, CEO of WearOptimo, tells us about progress with their new wearable. You could be dehydrated and not even know it … And exactly how hydrated are you right now, anyway? The old “if you’re thirsty, drink something” turns out to be a little too late.By Moira Gunn

1
The BioTech Nation session at NextMed Health 2025... Dr. Daniel Kraft, Tech Nation Health, Chief Correspondent 8:17

4M ago8:17

8:17

Tech Nation Health Chief Correspondent Daniel Kraft reports in on the BioTech Nation session from NextMed Health 2025By Moira Gunn

1
Insulin Cells WITHOUT Immunosuppressants... Dr. Steve Harr, CEO, Sana Biotechnology 14:58

4M ago14:58

14:58

This week on BioTech Nation, Dr. Steve Harr, CEO of Sana Biotechnology, talks about their progress in Type I diabetics, in particular. The New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without immunosuppressant drugs.By Moira Gunn

1
Focused Ultrasound - Treating Disease Without Surgery... Dr. Neil Kassell, Founder and Chair, Focused Ultrasound Foundation 18:21

4M ago18:21

18:21

This week on BioTech Nation, Dr. Neal Kassell, founder of the Focused Ultrasound Foundation, introduces us to a powerful, non-invasive technology that’s already changing lives, and it doesn’t involve surgery, injections, or pills.By Moira Gunn

1
A New Way to Treat Skin Cancer... No Surgery Required??? Dr. Raza Bokhari, CEO and Chairman, Medicus Pharma Ltd. 12:01

4M ago12:01

12:01

This week on BioTech Nation, Dr. Raza Bokhari, CEO of Medicus Pharma, shares a new non-surgical treatment approach for basal cell carcinoma, the most common form of skin cancer. Their novel microneedle patch delivers a powerful cancer drug directly into the skin, avoiding the scarring, cost, and discomfort of Mohs surgery. With promising phase 2 tr…

1
Part II: "Super Agers … An Evidenced-Based Approach to Longevity".... Dr. Eric Topol, Author, Prof., and EVP, Scripps Ranch 17:08

5M ago17:08

17:08

This week on BioTech Nation, Dr. Eric Topol returns to continue his conversation on, "Super Agers … An Evidenced-Based Approach to Longevity", his evidence-based approach to living longer, healthier lives. He shares why longevity must be accessible to everyone, not just the wealthy, and how new tools like AI, personalized diagnostics, and even gut …

1
Part I: "Super Agers … An Evidenced-Based Approach to Longevity".... Dr. Eric Topol, Author, Prof., and EVP, Scripps Ranch 21:53

5M ago21:53

21:53

This week on BioTech Nation, Dr. Eric Topol, professor and Executive Vice President at Scripps Research and author of "Super Agers … An Evidenced-Based Approach to Longevity", breaks down what science really says about aging well and what is just marketing. From immune-boosting cell therapy to the myth of magic longevity pills, Dr. Topol explains h…

1
Solving Genetic Diseases??? Dr. Neil Kumar, Founder & CEO, BridgeBio Pharma 23:18

5M ago23:18

23:18

This week on Biotech Nation, Dr. Neil Kumar, founder and CEO of BridgeBio Pharma. Dr. Kumar emphasizes that genetic diseases, particularly Mendelian diseases caused by single gene mutations, are solvable due to advancements in genetic measurement and understanding. He discusses BridgeBio Pharma's innovative corporate structure, which consists of mu…

1
No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation 16:10

6M ago16:10

16:10

Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three t…

1
The Science of a Stronger Heart... Robert Blum, CEO, CytoKinetics 15:47

6M ago15:47

15:47

This week on BioTech Nation, Robert Blum, CEO of CytoKinetics, joins me to talk about the company’s decades-long mission to keep hearts beating stronger and longer. With one heart drug under FDA review and more in the pipeline, CytoKinetics is working to address the full spectrum of heart failure, from weak hearts to overactive ones, and even explo…

1
When Wounds Won't Heal... Jason Matuszewski, CEO, BioStem Technologies 9:46

6M ago9:46

9:46

This week on BioTech Nation, BioSTEM Technologies CEO Jason Matuszewski explains how donated placental tissue is being used to treat chronic wounds that just won’t heal, from diabetic ulcers to pressure sores. With millions affected and traditional care often falling short, BioSTEM’s approach offers a new way to support healing and reduce scarring.…

1
Snake Bite Man meets Biotech Scientist creates Breakthrough Antivenom Vaccine … Dr. Jake Glanville, Founder, Chairman & CEO of Centivax 34:53

6M ago34:53

34:53

This week on BioTech Nation, Biotech Entrepreneur, Dr. Jake Glanville, Founder, Chair and CEO of Centivax, gives us the insider’s view of this Biotech Breakthrough – from the first telephone call through each significant step, all leading to the first breakthrough generalized antivenom vaccine in 125 years.…

1
What’s Next in Health? Highlights from NextMed 2025... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 11:29

7M ago11:29

11:29

This week on BioTech Nation, Dr. Daniel Kraft, Tech Nation Health Chief Correspondent, returns with highlights from the 2025 NextMed Health conference. From AI-powered health agents to voice-based disease detection, hear what’s emerging at the intersection of medicine, technology, and global health equity.…

1
How Can a Treatment Become a Vaccine??? Dr. Peter DeMuth, Chief Scientific Officer at Elicio Therapeutics 23:33

7M ago23:33

23:33

Dr. Peter DeMuth, Chief Scientific Officer of Elicio Therapeutics, discusses the revolutionary approach of detecting cancer at its earliest stages through circulating tumor DNA (ctDNA) tests. Highlighting their innovative treatment method, which aims to train the body's immune cells to recognize and destroy cancer cells, the episode explores the po…

1
PART II: A Regenerative Leap for Epilepsy… Dr. Cory Nicholas, Co-Founder and CEO, Neurona Therapeutics 27:03

7M ago27:03

27:03

This week on BioTech Nation, Dr. Cory Nicholas, CEO of Neurona Therapeutics, returns for part two. With early results now in from Neurona’s first clinical trial, patients with severe epilepsy are seeing dramatic improvements, including seizure reductions of over 90 percent, and even full remission in some cases. This one-time treatment delivers new…

1
PART 1: A Regenerative Leap for Epilepsy…Dr. Cory Nicholas, Co-Founder and CEO, Neurona Therapeutics 24:27

8M ago24:27

24:27

This week on BioTech Nation, Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, discusses their groundbreaking success in treating drug-resistant epilepsy. With a single, targeted delivery of lab-grown brain cells, Neurona is offering not just symptom control but the possibility of long-term seizure relief. This is Part 1 of a two-part …

1
Fighting Cancer, Easing Pain... Dr. Lorin Johnson, CSO, Glycyx Therapeutics 17:23

8M ago17:23

17:23

This week on BioTech Nation, we explore a new approach to cancer treatment that could help patients manage pain without compromising their care. Dr. Lorin Johnson, CSO of Glycyx Therapeutics explains how a new once-daily pill could help patients manage pain without blocking their treatment.By Moira Gunn

1
Freezing Out Chronic Pain…Sameer Sabir CEO, Brixton Biosciences 14:21

8M ago14:21

14:21

This week on BioTech Nation, Sameer Sabir, CEO of Brixton Biosciences, shares how their breakthrough injectable cold therapy, Neural Ice, could offer lasting relief for osteoarthritis pain. With a drug-free, nerve-targeting approach currently in clinical trials, this innovation may change how we treat joint pain without pills or repeated steroid in…

1
Beyond the One-Size-Fits-All Cure... Jeff Liter, Founder & CEO, Luminary Therapeutics 11:21

8M ago11:21

11:21

This week on BioTech Nation, Luminary Therapeutics CEO Jeff Liter shares how his team is working to make advanced cell therapy easier to access and more affordable. Instead of using each patient’s own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lu…

1
Beyond Pills and Shots... Sean Ainsworth, CEO, Immusoft 12:44

8M ago12:44

12:44

This week on BioTech Nation, Sean Ainsworth, CEO of ImmuSoft, explains how modifying the body’s own B cells to produce therapeutic proteins could revolutionize drug delivery. From improving treatment for rare diseases like Hurler syndrome to potentially replacing injections for autoimmune and metabolic conditions, this new approach opens the door t…

1
Breaking Barriers in Brain Cancer... Dr. Thomas Chen, Founder and CEO, NeOnc Technologies 24:39

9M ago24:39

24:39

This week on BioTech Nation, Dr. Thomas Chen, Director of Neuro-Oncology at USC and Founder of NeOnc Technologies, shares treating glioblastoma by delivering a drug directly to the brain through nasal inhalation changes the drug delivery game, bypassing the blood-brain barrier. This technique is achieving results in clinical trials.…

1
The Future of Synthetic Biology... Dr. John Cumbers, Founder & CEO, SynBioBeta 18:53

9M ago18:53

18:53

This week on BioTech Nation, I speak with Dr. John Cumbers, founder and CEO of SynBioBeta, the annual synthetic biology conference. We discuss how biology, AI, and technology are transforming industries, covering tracks on human health, planetary health, and hyperscale biology. SynBioBeta 2025 will take place in San Jose, CA, from May 5 to 8.…

1
Reimagining Bone Marrow Transplants... Kevin Caldwell, Co-Founder & CEO, Ossium Health 13:29

9M ago13:29

13:29

This week on BioTech Nation, Ossium Health co-founder and CEO Kevin Caldwell shares how their breakthrough approach is changing bone marrow transplants. By cryobanking marrow from organ donors, Ossium is reducing wait times, improving access, and preparing for future emergencies. With support from BARDA and promising clinical trial results, this ne…

1
When Your Immune System Attacks You... Prof. Dr. Niels Riedemann, Co-Founder & CEO, Inflarx 21:52

9M ago21:52

21:52

This week on BioTech Nation, we explore what happens when your immune system overreacts. Professor Niels Riedemann, CEO of InflaRx, explains how the body’s defense system can sometimes cause more harm than good, leading to serious conditions like rheumatoid arthritis, severe COVID-19, and lung failure. Learn how InflaRx is developing treatments to …

1
Designing Healthcare for People... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 7:59

10M ago7:59

7:59

This week on BioTech Nation, Dr. Daniel Kraft explores how smarter design can make healthcare easier, less stressful, and more effective. From hospitals built for patient comfort to medical apps that adapt to your needs, the way we experience healthcare is evolving. Learn how design thinking and empathy are shaping the future of medicine.…

1
Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals 19:01

10M ago19:01

19:01

This week on BioTech Nation, Catalyst Pharmaceuticals CEO Rich Daly discusses the complexities of treating epilepsy and rare diseases. From the challenges of polypharmacy—where patients need multiple drugs to manage a single condition—to the hurdles of diagnosing and treating ultra-rare diseases.By Moira Gunn

1
A Second Chance for an ALS Drug... Dr. Ari Azhir, Founder & CEO, Neuvivo 17:47

10M ago17:47

17:47

This week on Biotech Nation, Dr. Ari Azhir, Founder and CEO of Neuvivo, shares the incredible journey of an ALS drug that was once abandoned, but is now making its way toward FDA approval. After two failed phase two trials, the drug was left behind until Dr. Azhir and her team discovered a crucial mistake in the trial data. Now with new insights an…

1
The Mystery of "Dark" Proteins... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 9:29

10M ago9:29

9:29

This week on BioTech Nation, Dr. Daniel Kraft explores the discovery of "dark" proteins, thousands of previously unknown proteins in the human body. Scientists believe these hidden proteins could be the key to detecting diseases earlier and developing new treatments.By Moira Gunn